Press Releases

Current Articles | Categories | Search | Syndication

25 March 2014  Joanne Hunter
Siemens shares future developments and intelligence around Free Light Chains with BN customers
By Joanne Hunter @ 14:29 :: 176 Views

Siemens Healthcare Diagnostics recently held a BN™II and BN ProSpec® Customer Connection Event in Birmingham, providing delegates with updates on the latest developments and tools available. The two-day event attracted customers using the plasma protein systems from all across the UK and provided an opportunity to interact with colleagues and Siemens experts to share experience and best practice.

Read More

25 February 2014  Joanne Hunter
HORIBA Medical Launches Compact Multifunctional Haematology Analyser
By Joanne Hunter @ 09:38 :: 277 Views


Northampton, UK– 24th February 2014 – HORIBA UK Ltd, Medical Division
, has launched the new Pentra XLR compact 5 part DIFF haematology analyser incorporating full reticulocyte parameters to facilitate the investigation and diagnosis of haemopoiesis and anaemia. As the latest addition to the Pentra family, the XLR brings HORIBA’s gold standard reticulocyte technology with STAT capabilities to a smaller platform. This makes it ideal for space-restricted laboratories or those with a smaller workload that do not want to compromise on quality.

Read More

25 February 2014  Joanne Hunter
PLACING TO RAISE £5 MILLION
By Joanne Hunter @ 09:14 :: 283 Views


24th February 2014, Cobham, UK – Proteome Sciences plc (“Proteome Sciences” or the “Company”) is pleased to announce that it has conditionally placed 17,857,143 new ordinary shares of 1p each (“New Ordinary Shares”) to raise £5 million before expenses with new and existing investors (the “Placing”) at 28p per share (the “Placing Price”) to provide additional working capital for the Company. Christopher Pearce, Chief Executive of the Proteome Sciences, has subscribed for 3,571,429 New Ordinary Shares in the Placing at the Placing Price. Following this transaction Christopher Pearce will hold 35,109,504 ordinary shares in the Company representing 16.4 per cent. of the Company’s enlarged share capital.

Read More

19 February 2014  Joanne Hunter
Fast Frozen – Ready-to-Use Plasma Products Improve Quality and Process Flow
By Joanne Hunter @ 09:03 :: 590 Views



Compared to traditional lyophilised plasma controls, the Precision BioLogic (Nova Scotia, Canada), range of CRYOcheckTM Factor Deficient Plasmas provide significant quality and productivity improvements for the haemostasis laboratory. Exclusively available in the UK from Alpha Laboratories (Hampshire, UK), these frozen, platelet-poor plasmas are immunodepleted and assayed at less than 1% for the specific factor, by functional and antigenic methods*. The plasma is buffered and frozen, resulting in an excellent quality product that is consistent vial to vial.

Read More

12 February 2014  Joanne Hunter
DiaSorin marks significant growth in molecular extraction kit sales
By Joanne Hunter @ 13:27 :: 274 Views


Italian Voden Medical Instruments S.p.A. awarded DiaSorin Platinum Distributor status

The Milan-based Life Science Division of Voden Medical Instruments S.p.A. has been awarded DiaSorin Platinum Distributor status in recognition of their outstanding contribution to sales of the DiaSorin Arrow instrument and molecular extraction kits throughout Italy.  Meeting the specific needs of HLA (human leukocyte antigen) testing laboratories, assessing tissue compatibility in organ transplant patients, the Arrow Blood DNA extraction kit has shown particular growth and completes the Voden product offering for this important molecular investigation.

Read More

12 February 2014  Joanne Hunter
TRADING UPDATE
By Joanne Hunter @ 11:40 :: 269 Views


7th February, 2014 - Cobham, UK. The Directors would like to update shareholders on the Company’s trading activities. Revenue for 2013 is expected to show a significant increase over 2012 resulting from the strong performance across our core activities.

Read More

12 February 2014  Joanne Hunter
Sepsis-Diagnostics.co.uk- New Dedicated Website for Rapid Pathogen ID
By Joanne Hunter @ 09:36 :: 718 Views



www.Sepsis-Diagnostics.co.uk is now live. This dedicated website developed by Alpha Laboratories provides a valuable resource regarding the serious issue of sepsis. A systemic inflammatory response to a microbial infection, sepsis occurs in 1 in 23 patients admitted to hospital and has a tragic 16% mortality rate.

Read More

11 February 2014  Joanne Hunter
Tri-Con 2014 – EKF Molecular to showcase PointMan™ DNA-enrichment kits
By Joanne Hunter @ 08:56 :: 285 Views

Cardiff, UK – 10th February 2014

EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, announces that its subsidiary company EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan™ DNA-enrichment technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.

Read More

04 February 2014  Joanne Hunter
Siemens Healthcare Diagnostics partners with Pfizer to develop companion diagnostics
By Joanne Hunter @ 12:05 :: 296 Views


Siemens Healthcare Diagnostics has announced that it has entered into a collaboration agreement with Pfizer, the world's largest research-based pharmaceutical company, to design, develop and commercialise diagnostic tests for therapeutic products across Pfizer’s pipeline. Under the agreement, Siemens will be one of Pfizer's collaboration partners to develop and provide in vitro diagnostic tests for use in clinical studies and, potentially, eventual global commercialisation with Pfizer products.

Read More

31 January 2014  Joanne Hunter
Dr. Peter Wrighton-Smith Named UK BioIndustry Association (BIA) Entrepreneur of the Year
By Joanne Hunter @ 12:25 :: 309 Views



OXFORD, UK and MARLBOROUGH, MA, January. 31, 2014 (GLOBE NEWSWIRE) – Oxford Immunotec Global PLC (Nasdaq: OXFD) announced today that its CEO, Dr. Peter Wrighton-Smith has been named the UK BioIndustry Association Entrepreneur of the Year.

Read More

Previous Page | Next Page